“有病去医院……”王老吉12个字怒怼加多宝

Core Viewpoint - The ongoing trademark dispute between Wanglaoji and JDB (Jiangsu Dahe Beverage) has intensified, focusing on the overseas trademark ownership of "Wanglaoji" [3][22]. Group 1: Trademark Dispute Developments - JDB recently claimed ownership of the overseas trademark rights for "Wanglaoji," citing victories in multiple legal cases in Canada and the EU [6][9]. - Wanglaoji responded sharply, asserting that the trademark rights belong to Guangzhou Pharmaceutical Group and accusing JDB of maliciously registering trademarks to hinder their international expansion [15][19]. - The dispute has historical roots dating back to 2011, with both companies engaging in a protracted legal battle over trademark rights [33][34]. Group 2: Legal Victories and Strategies - JDB's Multi Access Limited successfully defended its trademark rights in Canadian and EU courts, marking significant progress in its international branding strategy [7][9]. - JDB has established trademark rights in over 60 countries and regions, positioning itself as the legitimate rights holder for the "Wanglaoji" brand globally [11][14]. - Wanglaoji has also been proactive in its international strategy, launching the English brand "WALOVI" and expanding its product offerings to international markets [28][30]. Group 3: Market Position and Financial Performance - Wanglaoji reported a revenue of 6.499 billion yuan in the first half of 2025, reflecting an 8.38% year-on-year growth, with profits also increasing significantly [27]. - The plant-based beverage market is experiencing rapid growth, with a compound annual growth rate of nearly 10% from 2019 to 2024, indicating a favorable environment for both brands [31]. - As of June 2025, Wanglaoji holds a 46.33% market share in the plant beverage category in China, while JDB follows with 28.31% [31].